search
Back to results

Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris

Primary Purpose

Acne Vulgaris

Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
CD5789 (trifarotene) 50μg/g cream
Placebo cream
Sponsored by
Galderma R&D
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acne Vulgaris focused on measuring Efficacy, Safety, Acne vulgaris

Eligibility Criteria

9 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • The subject is a male or female, 9 years of age or older, at Screening visit.
  • The Subject has moderate acne at Screening and Baseline.
  • The subject is a female of non childbearing potential
  • The subject is a female of childbearing potential with a negative pregnancy test and who is strictly abstinent or who agrees to use an effective and approved contraceptive method for the duration of the study and at least 1 month after the last study drug application.

Exclusion Criteria:

  • The subject has severe forms of acne (e.g., acne conglobate, acne fulminant) or secondary acne form (e.g.,chloracne, drug-induced acne, etc.).
  • The subject has any uncontrolled or serious disease or any medical or surgical condition that may either interfere with the interpretation of the trial results and/or put the subject at significant risk (according to the Investigator's judgment) if the subject takes part to the trial.
  • The subject has been exposed to excessive ultraviolet (UV) radiation within one month prior to the Baseline visit or the subject is planning intense UV exposure during the study (i.e., occupational exposure to the sun, sunbathing, tanning salon use, phototherapy, etc.)
  • The subject is unwilling to refrain from use of prohibited medication during the clinical trial

Sites / Locations

  • Galderma Investigational Site (8258)
  • Galderma Investigational Site (# 8530)
  • Galderma Investigational Site (# 8511)
  • Galderma Investigational Site (# 8009)
  • Galderma Investigational Site (# 8355)
  • Galderma Investigational Site (# 8456)
  • Galderma Investigational site (8578)
  • Galderma Investigational Site (# 8526)
  • Galderma Investigational Site (8577)
  • Galderma Investigational Site (# 8224)
  • Galderma Investigational Site (# 8509)
  • Galderma Investigational Site (# 8507)
  • Galderma Investigational Site (# 8425)
  • Galderma Investigational Site (# 8052)
  • Galderma Investigational Site (# 8528)
  • Galderma Investigational Site (# 8160)
  • Galderma Investigational Site (# 8443)
  • Galderma Investigational Site (8572)
  • Galderma Investigational Site (# 8510)
  • Galderma Investigational Site (# 8370)
  • Galderma Investigational Site (# 8543)
  • Galderma Investigational Site (8143)
  • Galderma Investigational site (8259)
  • Galderma Investigational Site (# 8522)
  • Galderma Investigational Site (# 8531)
  • Galderma Investigational Site (8502)
  • Galderma Investigational Site (#8213)
  • Galderma Investigational Site (# 8455)
  • Galderma Investigational Site (# 8529)
  • Galderma Investigational Site (# 8523)
  • Galderma Investigational Site (# 8126)
  • Galderma Investigational Site (#8189)
  • Galderma Investigational Site (8582)
  • Galderma Investigational Site (# 8367)
  • Galderma Investigational Site (8191)
  • Galderma Investigational site (8571)
  • Galderma Investigational Site (8575)
  • Galderma Investigational Site (# 8366)
  • Galderma Investigational Site (# 8532)
  • Galderma Investigational Site (# 8069)
  • Galderma Investigational Site (8092)
  • Galderma Investigational Site (8545)
  • Galderma Investigational Site (8457)
  • Galderma Investigational site (8580)
  • Galderma Investigational Site (# 8012)
  • Galderma Investigational Site (# 8525)
  • Galderma Investigational Site (# 8541)
  • Galderma Investigational Site (#8512)
  • Galderma Investigational Site (8574)
  • Galderma Investigational Site (#8033)
  • Galderma Investigational Site (8129)
  • Galderma Investigational Site (# 8226)
  • Galderma Investigational Site (# 8521)
  • Galderma Investigational Site (#8027)
  • Galderma Investigational Site (# 8544)
  • Galderma Investigational Site (# 8108)
  • Galderma Investigational Site (#8420)
  • Galderma Investigational Site (# 8506)
  • Galderma Investigational Site (#8500)
  • Galderma Investigational Site (8524)
  • Galderma Investigational Site (8568)
  • Galderma Investigational Site (8585)
  • Galderma Investigational Site (8279)
  • Galderma Investigational Site (8566)
  • Galderma Investigational Site (#8514)
  • Galderma Investigational Site (# 8195)
  • Galderma Investigational Site (# 8016)
  • Galderma Investigational site (8595)
  • Galderma Investigational Site (8188)
  • Galderma Investigational site (8353)
  • Galderma Investigational Site (# 8369)
  • Galderma Investigational Site (# 8117)
  • Galderma Investigational Site (# 8515)
  • Galderma Investigational Site (# 8542)
  • Galderma Investigational Site (#8513)
  • Galderma Investigational site (8579)
  • Galderma Investigational Site (# 8245)
  • Galderma Investigational Site (8183)
  • Galderma Investigational site (8576)
  • Galderma Investigational Site (8583)
  • Galderma Investigational Site (8567)
  • Galderma Investigational site (8433)
  • Galderma Investigational site (8329)
  • Galderma Investigational site (8106)
  • Galderma Investigational Site (# 8214)
  • Galderma Investigational Site (# 8351)
  • Galderma Investigational Site (# 8215)
  • Galderma Investigational site (8161)
  • Galderma Investigational Site (# 8154)
  • Galderma Investigational Site (8586)
  • Galderma Investigational Site (# 8038)
  • Galderma Investigational Site (# 8426)
  • Galderma Investigational Site (# 8026)
  • Galderma Investigational Site (# 8135)
  • Galderma Investigational Site (# 8168)
  • Galderma Investigational Site (# 8340)
  • Galderma Investigational Site (# 8338)
  • Galderma Investigational Site (8001)
  • Galderma Investigational Site (# 8060)
  • Galderma Investigational Site (5566)
  • Galderma Investigational Site (5604)
  • Galderma Investigational Site (5815)
  • Galderma Investigational Site (5750)
  • Galderma Investigational Site (5572)
  • Galderma Investigational Site (5204)
  • Galderma Investigational Site (5434)
  • Galderma Investigational Site (5146)
  • Galderma Investigational Site (5838)
  • Galderma Investigational Site (5635)
  • Galderma Investigational Site (5543)
  • Galderma Investigational Site (5307)
  • Galderma Investigational Site (5802)
  • Galderma Investigational Site (5567)
  • Galderma Investigational Site (5812)
  • Galderma Investigational Site (5685)
  • Galderma Investigational Site (5254)
  • Galderma Investigational Site (5811)
  • Galderma Investigational Site (5263)
  • Galderma Investigational Site (5237)
  • Galderma Investigational Site (5767)
  • Galderma Investigational Site (8592)
  • Galderma Investigational Site (8594)
  • Galderma Investigational site (8100)
  • Galderma Investigational Site (8593)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

CD5789 (trifarotene) 50μg/g Cream

Placebo Cream

Arm Description

CD5789 (trifarotene) 50μg/g Cream

Placebo cream

Outcomes

Primary Outcome Measures

Investigator Global Assessment (IGA) Success Rate at Week 12
Number of subjects who achieved an Investigator Global Assessment (IGA) score of 1 (almost clear) or 0 (Clear) and at least a 2-grade improvement from Baseline to Week 12.

Secondary Outcome Measures

Full Information

First Posted
October 1, 2015
Last Updated
October 28, 2019
Sponsor
Galderma R&D
search

1. Study Identification

Unique Protocol Identification Number
NCT02566369
Brief Title
Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris
Official Title
A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris
Study Type
Interventional

2. Study Status

Record Verification Date
July 2018
Overall Recruitment Status
Completed
Study Start Date
November 30, 2015 (Actual)
Primary Completion Date
November 14, 2017 (Actual)
Study Completion Date
November 14, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Galderma R&D

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Assessment of the efficacy and safety of CD5789 (trifarotene) 50μg/g cream applied once daily for 12 weeks in subjects with acne vulgaris.
Detailed Description
Clinical Trial for each subject is approximately 14 weeks and are randomized to one of the two treatments for 12 weeks. Subjects must be 9 years of age and older with acne vulgaris.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acne Vulgaris
Keywords
Efficacy, Safety, Acne vulgaris

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
1208 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CD5789 (trifarotene) 50μg/g Cream
Arm Type
Experimental
Arm Description
CD5789 (trifarotene) 50μg/g Cream
Arm Title
Placebo Cream
Arm Type
Placebo Comparator
Arm Description
Placebo cream
Intervention Type
Drug
Intervention Name(s)
CD5789 (trifarotene) 50μg/g cream
Intervention Description
CD5789 (trifarotene) 50µg/g cream applied once daily for 12 weeks.
Intervention Type
Drug
Intervention Name(s)
Placebo cream
Intervention Description
Placebo cream applied once daily for 12 weeks
Primary Outcome Measure Information:
Title
Investigator Global Assessment (IGA) Success Rate at Week 12
Description
Number of subjects who achieved an Investigator Global Assessment (IGA) score of 1 (almost clear) or 0 (Clear) and at least a 2-grade improvement from Baseline to Week 12.
Time Frame
From Baseline to Week 12

10. Eligibility

Sex
All
Minimum Age & Unit of Time
9 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The subject is a male or female, 9 years of age or older, at Screening visit. The Subject has moderate acne at Screening and Baseline. The subject is a female of non childbearing potential The subject is a female of childbearing potential with a negative pregnancy test and who is strictly abstinent or who agrees to use an effective and approved contraceptive method for the duration of the study and at least 1 month after the last study drug application. Exclusion Criteria: The subject has severe forms of acne (e.g., acne conglobate, acne fulminant) or secondary acne form (e.g.,chloracne, drug-induced acne, etc.). The subject has any uncontrolled or serious disease or any medical or surgical condition that may either interfere with the interpretation of the trial results and/or put the subject at significant risk (according to the Investigator's judgment) if the subject takes part to the trial. The subject has been exposed to excessive ultraviolet (UV) radiation within one month prior to the Baseline visit or the subject is planning intense UV exposure during the study (i.e., occupational exposure to the sun, sunbathing, tanning salon use, phototherapy, etc.) The subject is unwilling to refrain from use of prohibited medication during the clinical trial
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jerry Tan, MD
Organizational Affiliation
Windsor Clinical Research
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ulrike Blume-Peytavi, MD
Organizational Affiliation
Charité Universitätsmedizin
Official's Role
Principal Investigator
Facility Information:
Facility Name
Galderma Investigational Site (8258)
City
Mobile
State/Province
Alabama
ZIP/Postal Code
36608
Country
United States
Facility Name
Galderma Investigational Site (# 8530)
City
Glendale
State/Province
Arizona
ZIP/Postal Code
85308
Country
United States
Facility Name
Galderma Investigational Site (# 8511)
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85018
Country
United States
Facility Name
Galderma Investigational Site (# 8009)
City
Hot Springs
State/Province
Arkansas
ZIP/Postal Code
71913
Country
United States
Facility Name
Galderma Investigational Site (# 8355)
City
Rogers
State/Province
Arkansas
ZIP/Postal Code
72758
Country
United States
Facility Name
Galderma Investigational Site (# 8456)
City
Beverly Hills
State/Province
California
ZIP/Postal Code
90212
Country
United States
Facility Name
Galderma Investigational site (8578)
City
Cerritos
State/Province
California
ZIP/Postal Code
90703
Country
United States
Facility Name
Galderma Investigational Site (# 8526)
City
Clovis
State/Province
California
ZIP/Postal Code
93612
Country
United States
Facility Name
Galderma Investigational Site (8577)
City
Encinitas
State/Province
California
ZIP/Postal Code
92024
Country
United States
Facility Name
Galderma Investigational Site (# 8224)
City
Fremont
State/Province
California
ZIP/Postal Code
94538
Country
United States
Facility Name
Galderma Investigational Site (# 8509)
City
Fullerton
State/Province
California
ZIP/Postal Code
92835
Country
United States
Facility Name
Galderma Investigational Site (# 8507)
City
Huntington Beach
State/Province
California
ZIP/Postal Code
92647
Country
United States
Facility Name
Galderma Investigational Site (# 8425)
City
Newport Beach
State/Province
California
ZIP/Postal Code
92663
Country
United States
Facility Name
Galderma Investigational Site (# 8052)
City
Oceanside
State/Province
California
ZIP/Postal Code
92056
Country
United States
Facility Name
Galderma Investigational Site (# 8528)
City
Santa Ana
State/Province
California
ZIP/Postal Code
92701
Country
United States
Facility Name
Galderma Investigational Site (# 8160)
City
Santa Monica
State/Province
California
ZIP/Postal Code
91301
Country
United States
Facility Name
Galderma Investigational Site (# 8443)
City
Temecula
State/Province
California
ZIP/Postal Code
92592
Country
United States
Facility Name
Galderma Investigational Site (8572)
City
Colorado Springs
State/Province
Colorado
ZIP/Postal Code
80920
Country
United States
Facility Name
Galderma Investigational Site (# 8510)
City
Englewood
State/Province
Colorado
ZIP/Postal Code
80113
Country
United States
Facility Name
Galderma Investigational Site (# 8370)
City
Boynton Beach
State/Province
Florida
ZIP/Postal Code
33437
Country
United States
Facility Name
Galderma Investigational Site (# 8543)
City
Fort Lauderdale
State/Province
Florida
ZIP/Postal Code
33316
Country
United States
Facility Name
Galderma Investigational Site (8143)
City
Miami
State/Province
Florida
ZIP/Postal Code
33175
Country
United States
Facility Name
Galderma Investigational site (8259)
City
Miramar
State/Province
Florida
ZIP/Postal Code
33027
Country
United States
Facility Name
Galderma Investigational Site (# 8522)
City
North Miami Beach
State/Province
Florida
ZIP/Postal Code
33162
Country
United States
Facility Name
Galderma Investigational Site (# 8531)
City
Orange Park
State/Province
Florida
ZIP/Postal Code
32073
Country
United States
Facility Name
Galderma Investigational Site (8502)
City
Orlando
State/Province
Florida
ZIP/Postal Code
32814
Country
United States
Facility Name
Galderma Investigational Site (#8213)
City
Ormond Beach
State/Province
Florida
ZIP/Postal Code
32174
Country
United States
Facility Name
Galderma Investigational Site (# 8455)
City
Saint Petersburg
State/Province
Florida
ZIP/Postal Code
33708
Country
United States
Facility Name
Galderma Investigational Site (# 8529)
City
Sanford
State/Province
Florida
ZIP/Postal Code
32771
Country
United States
Facility Name
Galderma Investigational Site (# 8523)
City
Tampa
State/Province
Florida
ZIP/Postal Code
33609
Country
United States
Facility Name
Galderma Investigational Site (# 8126)
City
West Palm Beach
State/Province
Florida
ZIP/Postal Code
33401
Country
United States
Facility Name
Galderma Investigational Site (#8189)
City
Snellville
State/Province
Georgia
ZIP/Postal Code
30078
Country
United States
Facility Name
Galderma Investigational Site (8582)
City
Idaho Falls
State/Province
Idaho
ZIP/Postal Code
83404
Country
United States
Facility Name
Galderma Investigational Site (# 8367)
City
Arlington Heights
State/Province
Illinois
ZIP/Postal Code
60005
Country
United States
Facility Name
Galderma Investigational Site (8191)
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611
Country
United States
Facility Name
Galderma Investigational site (8571)
City
Darien
State/Province
Illinois
ZIP/Postal Code
60561
Country
United States
Facility Name
Galderma Investigational Site (8575)
City
Oakbrook Terrace
State/Province
Illinois
ZIP/Postal Code
60180
Country
United States
Facility Name
Galderma Investigational Site (# 8366)
City
Plainfield
State/Province
Indiana
ZIP/Postal Code
46168
Country
United States
Facility Name
Galderma Investigational Site (# 8532)
City
Overland Park
State/Province
Kansas
ZIP/Postal Code
66215
Country
United States
Facility Name
Galderma Investigational Site (# 8069)
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40202
Country
United States
Facility Name
Galderma Investigational Site (8092)
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40217
Country
United States
Facility Name
Galderma Investigational Site (8545)
City
Owensboro
State/Province
Kentucky
ZIP/Postal Code
42301
Country
United States
Facility Name
Galderma Investigational Site (8457)
City
Monroe
State/Province
Louisiana
ZIP/Postal Code
71203
Country
United States
Facility Name
Galderma Investigational site (8580)
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70130
Country
United States
Facility Name
Galderma Investigational Site (# 8012)
City
Glenn Dale
State/Province
Maryland
ZIP/Postal Code
20769
Country
United States
Facility Name
Galderma Investigational Site (# 8525)
City
Rockville
State/Province
Maryland
ZIP/Postal Code
20850
Country
United States
Facility Name
Galderma Investigational Site (# 8541)
City
Quincy
State/Province
Massachusetts
ZIP/Postal Code
02169
Country
United States
Facility Name
Galderma Investigational Site (#8512)
City
Bay City
State/Province
Michigan
ZIP/Postal Code
48706
Country
United States
Facility Name
Galderma Investigational Site (8574)
City
Clarkston
State/Province
Michigan
ZIP/Postal Code
48346
Country
United States
Facility Name
Galderma Investigational Site (#8033)
City
Clinton Township
State/Province
Michigan
ZIP/Postal Code
48038
Country
United States
Facility Name
Galderma Investigational Site (8129)
City
Fort Gratiot
State/Province
Michigan
ZIP/Postal Code
48059
Country
United States
Facility Name
Galderma Investigational Site (# 8226)
City
Warren
State/Province
Michigan
ZIP/Postal Code
48088
Country
United States
Facility Name
Galderma Investigational Site (# 8521)
City
Saint Joseph
State/Province
Missouri
ZIP/Postal Code
64506
Country
United States
Facility Name
Galderma Investigational Site (#8027)
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63141
Country
United States
Facility Name
Galderma Investigational Site (# 8544)
City
Lincoln
State/Province
Nebraska
ZIP/Postal Code
68502
Country
United States
Facility Name
Galderma Investigational Site (# 8108)
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89144
Country
United States
Facility Name
Galderma Investigational Site (#8420)
City
Newington
State/Province
New Hampshire
ZIP/Postal Code
03801
Country
United States
Facility Name
Galderma Investigational Site (# 8506)
City
Hackensack
State/Province
New Jersey
ZIP/Postal Code
07601
Country
United States
Facility Name
Galderma Investigational Site (#8500)
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11203
Country
United States
Facility Name
Galderma Investigational Site (8524)
City
East Setauket
State/Province
New York
ZIP/Postal Code
11733
Country
United States
Facility Name
Galderma Investigational Site (8568)
City
New York
State/Province
New York
ZIP/Postal Code
10022
Country
United States
Facility Name
Galderma Investigational Site (8585)
City
New York
State/Province
New York
ZIP/Postal Code
10028
Country
United States
Facility Name
Galderma Investigational Site (8279)
City
New York
State/Province
New York
ZIP/Postal Code
10075
Country
United States
Facility Name
Galderma Investigational Site (8566)
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28277
Country
United States
Facility Name
Galderma Investigational Site (#8514)
City
Hickory
State/Province
North Carolina
ZIP/Postal Code
28602
Country
United States
Facility Name
Galderma Investigational Site (# 8195)
City
Beachwood
State/Province
Ohio
ZIP/Postal Code
44122
Country
United States
Facility Name
Galderma Investigational Site (# 8016)
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45255
Country
United States
Facility Name
Galderma Investigational site (8595)
City
Dublin
State/Province
Ohio
ZIP/Postal Code
43016
Country
United States
Facility Name
Galderma Investigational Site (8188)
City
Hershey
State/Province
Pennsylvania
ZIP/Postal Code
17033
Country
United States
Facility Name
Galderma Investigational site (8353)
City
Yardley
State/Province
Pennsylvania
ZIP/Postal Code
19067
Country
United States
Facility Name
Galderma Investigational Site (# 8369)
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29414
Country
United States
Facility Name
Galderma Investigational Site (# 8117)
City
Knoxville
State/Province
Tennessee
ZIP/Postal Code
37917
Country
United States
Facility Name
Galderma Investigational Site (# 8515)
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37203
Country
United States
Facility Name
Galderma Investigational Site (# 8542)
City
Arlington
State/Province
Texas
ZIP/Postal Code
76017
Country
United States
Facility Name
Galderma Investigational Site (#8513)
City
Austin
State/Province
Texas
ZIP/Postal Code
78705
Country
United States
Facility Name
Galderma Investigational site (8579)
City
Beaumont
State/Province
Texas
ZIP/Postal Code
77701
Country
United States
Facility Name
Galderma Investigational Site (# 8245)
City
Dallas
State/Province
Texas
ZIP/Postal Code
75231
Country
United States
Facility Name
Galderma Investigational Site (8183)
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Facility Name
Galderma Investigational site (8576)
City
Katy
State/Province
Texas
ZIP/Postal Code
77949
Country
United States
Facility Name
Galderma Investigational Site (8583)
City
Murphy
State/Province
Texas
ZIP/Postal Code
75094
Country
United States
Facility Name
Galderma Investigational Site (8567)
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78213
Country
United States
Facility Name
Galderma Investigational site (8433)
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78218
Country
United States
Facility Name
Galderma Investigational site (8329)
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Facility Name
Galderma Investigational site (8106)
City
Layton
State/Province
Utah
ZIP/Postal Code
84041
Country
United States
Facility Name
Galderma Investigational Site (# 8214)
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84117
Country
United States
Facility Name
Galderma Investigational Site (# 8351)
City
Seattle
State/Province
Washington
ZIP/Postal Code
98104
Country
United States
Facility Name
Galderma Investigational Site (# 8215)
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T3A 2N1
Country
Canada
Facility Name
Galderma Investigational site (8161)
City
Surrey
State/Province
British Columbia
ZIP/Postal Code
V3V 0C6
Country
Canada
Facility Name
Galderma Investigational Site (# 8154)
City
Winnipeg
State/Province
Manitoba
ZIP/Postal Code
R3C 0N2
Country
Canada
Facility Name
Galderma Investigational Site (8586)
City
Barrie
State/Province
Ontario
ZIP/Postal Code
L4M 7G1
Country
Canada
Facility Name
Galderma Investigational Site (# 8038)
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8N 1V6
Country
Canada
Facility Name
Galderma Investigational Site (# 8426)
City
London
State/Province
Ontario
ZIP/Postal Code
N5X 2P1
Country
Canada
Facility Name
Galderma Investigational Site (# 8026)
City
Markham
State/Province
Ontario
ZIP/Postal Code
L3P 1X2
Country
Canada
Facility Name
Galderma Investigational Site (# 8135)
City
North Bay
State/Province
Ontario
ZIP/Postal Code
P1B 3Z7
Country
Canada
Facility Name
Galderma Investigational Site (# 8168)
City
Oakville
State/Province
Ontario
ZIP/Postal Code
L6J 7W5
Country
Canada
Facility Name
Galderma Investigational Site (# 8340)
City
Peterborough
State/Province
Ontario
ZIP/Postal Code
K9J 5K2
Country
Canada
Facility Name
Galderma Investigational Site (# 8338)
City
Richmond Hill
State/Province
Ontario
ZIP/Postal Code
L4B 1A5
Country
Canada
Facility Name
Galderma Investigational Site (8001)
City
Waterloo
State/Province
Ontario
ZIP/Postal Code
N2J 1C4
Country
Canada
Facility Name
Galderma Investigational Site (# 8060)
City
Windsor
State/Province
Ontario
ZIP/Postal Code
N8W 5L7
Country
Canada
Facility Name
Galderma Investigational Site (5566)
City
Augsburg
ZIP/Postal Code
86179
Country
Germany
Facility Name
Galderma Investigational Site (5604)
City
Berlin
ZIP/Postal Code
10117
Country
Germany
Facility Name
Galderma Investigational Site (5815)
City
Berlin
ZIP/Postal Code
13507
Country
Germany
Facility Name
Galderma Investigational Site (5750)
City
Darmstadt
ZIP/Postal Code
64283
Country
Germany
Facility Name
Galderma Investigational Site (5572)
City
Dessau
ZIP/Postal Code
6847
Country
Germany
Facility Name
Galderma Investigational Site (5204)
City
Dresden
ZIP/Postal Code
1097
Country
Germany
Facility Name
Galderma Investigational Site (5434)
City
Dresden
ZIP/Postal Code
1307
Country
Germany
Facility Name
Galderma Investigational Site (5146)
City
Eberstadt
ZIP/Postal Code
64297
Country
Germany
Facility Name
Galderma Investigational Site (5838)
City
Hamburg
ZIP/Postal Code
20354
Country
Germany
Facility Name
Galderma Investigational Site (5635)
City
Langenau
ZIP/Postal Code
89129
Country
Germany
Facility Name
Galderma Investigational Site (5543)
City
Mainz
ZIP/Postal Code
55131
Country
Germany
Facility Name
Galderma Investigational Site (5307)
City
Münster
ZIP/Postal Code
48149
Country
Germany
Facility Name
Galderma Investigational Site (5802)
City
Balatonfüred
ZIP/Postal Code
08230
Country
Hungary
Facility Name
Galderma Investigational Site (5567)
City
Budapest
ZIP/Postal Code
01036
Country
Hungary
Facility Name
Galderma Investigational Site (5812)
City
Budapest
ZIP/Postal Code
01125
Country
Hungary
Facility Name
Galderma Investigational Site (5685)
City
Cegléd
ZIP/Postal Code
02700
Country
Hungary
Facility Name
Galderma Investigational Site (5254)
City
Nyíregyháza
ZIP/Postal Code
4400
Country
Hungary
Facility Name
Galderma Investigational Site (5811)
City
Pécel
ZIP/Postal Code
02119
Country
Hungary
Facility Name
Galderma Investigational Site (5263)
City
Püspökladány
ZIP/Postal Code
4150
Country
Hungary
Facility Name
Galderma Investigational Site (5237)
City
Szeged
ZIP/Postal Code
6720
Country
Hungary
Facility Name
Galderma Investigational Site (5767)
City
Szekszàrd
ZIP/Postal Code
07100
Country
Hungary
Facility Name
Galderma Investigational Site (8592)
City
Aibonito
ZIP/Postal Code
705
Country
Puerto Rico
Facility Name
Galderma Investigational Site (8594)
City
Caguas
ZIP/Postal Code
727
Country
Puerto Rico
Facility Name
Galderma Investigational site (8100)
City
Carolina
ZIP/Postal Code
985
Country
Puerto Rico
Facility Name
Galderma Investigational Site (8593)
City
San Juan
ZIP/Postal Code
00909-3004
Country
Puerto Rico

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris

We'll reach out to this number within 24 hrs